ARTICLE | Finance
Weaving in China
China VC part of $12M round for GeneWeave to get molecular diagnostic to market
March 5, 2012 8:00 AM UTC
Last week's $12 million series A round for molecular diagnostics play GeneWeave Biosciences Inc. is designed to get a first product to market.
New investor Decheng Capital, a Chinese VC, led the round and existing investors Claremont Creek Ventures and X/Seed Capital also participated...